[1] Benbassat J, Gefel D, Larholt K, et al. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninetytwo cases. Arthritis Rheum, 1985,28:249-255. [2] Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975,292:344-347. [3] 甄莉,俞宝田,张成训,等.216例皮肌炎预后因素的统计分析中华皮肤科杂志,1999,32:25-27. [4] 薛莺,陈湘君,陈顺乐,等.皮肌炎119例的预后分析.中华内科杂志,1997,36:32-35. [5] Hidano A, Kaneko K, Arai Y, et al. Survey of the prognosis fpr dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis. J Dermatol, 1986,13:233-241. [6] Yamagamin Y, Eto H, Arai H, et al. Clinical study of dermato myositis with interstitial pneumonia. 日皮云志, 1998,108:1021-1029. [7] 陈丽芳,李林峰皮肌炎合并肺间质病变临床皮肤科杂志,2002,31:217-218. [8] Grau JM, Miro O, Pedrol E, et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol, 1996,23:1921-1926. [9] Tanaka F, Origuchi T, Migita K, et at. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Intern Med. 2000,39:428-430. |